DRREDDY Dr Reddy's Laboratories Ltd US FDA Inspections Announcement 2024 - USFDA Response Letter USFDA issued a Complete Response Letter to Dr. Reddys Laboratories for their BLA for biosimilar rituximab DRL_RI..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Dr Reddy's Laboratories Ltd